Clinical trials
Phase 3 Psychotic Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| University of British Columbia | 2 |
| Bristol-Myers Squibb | 1 |
| GlaxoSmithKline | 1 |
| Nova Scotia Health Authority | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Solvay Pharmaceuticals | 1 |
| University of Oxford | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 10 |
| Schizophrenia | 7 |
| Bipolar Disorder | 2 |
| Alzheimer Disease | 1 |
| Dementia | 1 |
| Mental Disorders | 1 |
| Metabolic Syndrome | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.